Orion Pharma

Creating strong international partnerships via collaboration 🤝 This week, Orion had the pleasure of welcoming a business delegation from the Bavarian Ministry of Economic Affairs, Regional Development and Energy to discuss international co-operation in health data & management, AI and digital solutions. The delegation of Bavarian healthcare and research professionals were presented with Orion R&D's work in data and digital solutions by Sammeli Liikkanen as well as the Finnish approach to utilizing health dataspace by Dr. Heli Johanna Salminen of University of Helsinki and Health Capital Helsinki (HCH). Thank you for the engaging discussions and a keen interest in Orion’s work and our commitment to investments in R&D! Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie #orionpharma #HealthData #ResearchAndDevelopment

Orion and Lääketeollisuus ry / Pharma Industry Finland have today submitted the sector’s value proposition to Riikka Purra, the Minister of Finance. The industry wants to play its part in contributing to the Finnish Government’s plans for growth and is prepared to increase total investment in the pharmaceutical sector to EUR 1 billion by 2030. The health and pharmaceutical sector is one of the few industries that has increased its investments in Finland and its exports in recent years. According to preliminary data, the biggest increase in the value of exports in 2024 came from chemical industry products. Of these, exports of pharmaceutical products increased most, by 23.4%. Therefore, we believe that the pharmaceutical industry can play a key role in achieving Finland’s goal to increase R&D expenditure to 4% of GDP. This, however, requires a stronger strategic focus and continuous improvement of the operating environment. Read more ➡️ https://lnkd.in/dTKBwW4H #OrionPharma

In 2024, Orion promoted the use of renewable energy by covering all its district heating needs with renewable energy guarantees of origin, thereby supporting the development of renewable energy production in Finland. ☀️ As a result, Orion's combined market-based Scope 1 and Scope 2 emissions decreased by 21% compared to 2023. #OrionPharmaHighlights2024 

💡 Happiness is more than a feeling—it’s a structure built on trust, equality, and purpose. For years, Nordic countries have topped the UN’s World Happiness Report. Research shows that strong social connections and a sense of security play a key role in this. As a Nordic company, we at Orion believe that well-being is the foundation for innovation and more than just a personal pursuit. When people thrive, ideas do too. #WorldHappinessDay #NordicValues #OrionPharma

🔬 Understanding women’s health starts with inclusive research. Medical research has historically focused primarily on men, leaving significant gaps in our understanding of women’s health. Even today, many conditions affecting women are not studied as thoroughly as those affecting men, leading to delays in diagnosis and treatment. Fortunately, regulatory agencies are now requiring immediate action on diversity and inclusion in clinical trials. This shift is essential for everyone, not just for women. #HealthEquity #WomensHealth #MedicalResearch #OrionPharma

We invested EUR 180 million in research and development in 2024. 💰 Orion's innovative medicine research and development focuses on two growing therapeutic areas that are significant for both individuals and society: cancer and pain. Additionally, we develop generic and animal health products. #OrionPharmaHighlights2024 

In 2024, Orion’s products were sold in more than 100 countries. 🌍  Our goal is to be a truly global pharmaceutical company, helping people worldwide to live their lives to the fullest. We are proud that our products are now sold on four continents through us or our partners. #OrionPharmaHighlights2024 

🚨 Migraine is a major but often overlooked women’s health issue. 15% of women suffer from migraines—almost three times more than men. Many endure longer, more intense attacks while managing careers, families, and daily responsibilities. Despite significant advances in migraine treatment, too many women still go undiagnosed or untreated. Greater awareness, workplace flexibility, and better access to care can change lives. #Migraine #WomensHealth #Neurology #OrionPharma

💡 Investing in women’s health means investing in a stronger economy. According to the World Economic Forum, women spend 25% more of their lives in poor health compared to men, yet conditions like menopause, endometriosis, and PMS remain severely underfunded in research. At Orion, we have been dedicated to women’s well-being for decades, supporting their health at every stage of life. As we celebrate International Women’s Day, we must continue prioritizing women’s health in research, policy, and investment. #InternationalWomensDay #WomensHealth #HealthEquity #HealthEconomy #OrionPharma

It was a true honor to present the Finlandia Declaration to Prime Minister Petteri Orpo yesterday. Kemianteollisuus - Chemical Industry Federation of Finland, Teknologiateollisuus - Technology Industries of Finland, Finnish Forest Industries Federation and Energiateollisuus ry – Finnish Energy came together to propose concrete actions to accelerate the renewal of Finnish industry and drive sustainable growth. The entire export industry, along with the energy sector, calls for industrial operating and growth conditions to be placed at the forefront of the political agenda. More than 200 companies that have signed the declaration reaffirm their commitment to renewal and the development of future solutions. Together, we can achieve great things. Together, we can ensure that Finland remains a global leader in sustainable growth and innovation.   Read more about the declaration ➡️ https://lnkd.in/d6-TyXQ3 #IndustrialInnovation #FutureGrowth